Arabic Arabic English English French French German German
dark

Immunomic Therapeutics Strengthens Leadership Team with Appointment of Robert Newman as Chief Business Officer

Immunomic Therapeutics, Inc. announced today that it has appointed Robert Newman as Chief Business Officer. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Kadmon’s Chronic GVHD Drug Wins First FDA Approval for Company

Next Post

InterSystems Recognised as a Leader by Independent Research Firm in Multimodel Data Platforms Evaluation

Related Posts
Total
0
Share